AMENDMENT TO RESTRICTED STOCK AGREEMENT
EX-10.22 5 ex10-22.htm EXHIBIT 10.22 ex10-22.htm
Exhibit 10.22
AMENDMENT TO RESTRICTED STOCK AGREEMENT
AMENDMENT dated August 30, 2012 (this “Amendment”) to the Restricted Stock Agreement (the “Agreement”) made as of May 7, 2010, by and between Mediware Information Systems, Inc., a New York corporation (the “Company”), and John M. Damgaard (the “Grantee”). Capitalized terms not defined in this Amendment shall have the meanings ascribed to them in the Agreement.
WITNESSETH:
WHEREAS, pursuant to Section 3.2 of the Plan, subject to the provisions of the Plan, the Compensation Committee of the Board of Directors has the authority and discretion to establish the terms, conditions, performance criteria, restrictions and other provisions of any award granted under the Plan; and
WHEREAS, the Company and the Grantee desire to amend Section 1(c) of the Agreement, as hereinafter provided.
NOW THEREFORE, in consideration of the mutual promises herein contained and other good and valuable consideration, the receipt of which hereby is acknowledged, the parties agree as follows:
1. Section 1(c) of the Agreement is hereby amended by deleting it in its entirety and replacing it with the following:
c. 11,250 of the Restricted Shares (the “Second Restricted Shares”) shall vest on August 30, 2012 if the Chief Executive Officer and the Compensation Committee of the Board of Directors determines that the performance metrics setting out the vesting requirements for the Restricted Shares are achieved. The performance metrics for the Restricted Shares shall be determined by the Compensation Committee of the Board of Directors and the Chief Executive Officer on or before June 30th, 2011.
2. Except as set forth in this Amendment, each and every provision of the Agreement in effect on the date hereof shall remain in full force and effect.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]
IN WITNESS WHEREOF, this Amendment has been duly executed as of the day and year first above written by the Company and the Grantee.
MEDIWARE INFORMATION SYSTEMS, INC.
By: ______________________________
Name:
Title:
_____________________________
John M. Damgaard
2